Surveillance of adverse events following immunization in China: Past, present, and future

被引:48
作者
Liu, Dawei [1 ]
Wu, Wendi [1 ,2 ]
Li, Keli [1 ]
Xu, Disha [1 ]
Ye, Jiakai [1 ]
Li, Li [1 ]
Wang, Huaqing [1 ]
机构
[1] Chinese Ctr Dis Control & Prevent, Natl Immunizat Program, Beijing 100050, Peoples R China
[2] Univ Tampere, Sch Hlth Sci, FI-33014 Tampere, Finland
关键词
Adverse events following immunization (AEFI); Surveillance; Vaccination; VACCINE SAFETY; POSTMARKETING SURVEILLANCE; VAERS;
D O I
10.1016/j.vaccine.2015.04.060
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Surveillance for adverse events following immunization (AEFI) is an important component of any national immunization program. In the People's Republic of China (China), a populous, middle-income country, development of an AEFI surveillance system began in 2005. In 2008, the AEFI surveillance system was implemented as a nationwide, online system and called the Chinese National AEFI Information System (CNAEFIS). Since then, CNAEFIS has provided useful, national-level data on vaccine safety. National AEFI surveillance guidelines were issued jointly by the Ministry of Health and the China Food and Drug Administration in 2010. This article reviews the development, status, and key aspects of the Chinese AEFI surveillance system, and describes challenges and future plans for vaccine safety assessment in China. (C) 2015 Published by Elsevier Ltd.
引用
收藏
页码:4041 / 4046
页数:6
相关论文
共 40 条
  • [1] The vaccine data link in Nha Trang, Vietnam: a progress report on the implementation of a database to detect adverse events related to vaccinations
    Ali, M
    Canh, DG
    Clemens, JD
    Park, JK
    von Seidlein, L
    Thiem, VD
    Tho, LH
    Trach, DD
    [J]. VACCINE, 2003, 21 (15) : 1681 - 1686
  • [2] [Anonymous], PEDIAT HLTH
  • [3] [Anonymous], REG APPR MAN ABN REA
  • [4] [Anonymous], CHIN J VACCINES IMMU
  • [5] [Anonymous], CHIN J VACCINES IMMU
  • [6] [Anonymous], 2007, CHIN J VACCINES IMMU
  • [7] Comparing data mining methods on the VAERS database
    Banks, D
    Woo, EJ
    Burwen, DR
    Perucci, P
    Braun, MM
    Ball, R
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2005, 14 (09) : 601 - 609
  • [8] A Bayesian neural network method for adverse drug reaction signal generation
    Bate, A
    Lindquist, M
    Edwards, IR
    Olsson, S
    Orre, R
    Lansner, A
    De Freitas, RM
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (04) : 315 - 321
  • [9] Standardized case definitions of adverse events following immunization (AEFI)
    Bonhoeffer, J
    Heininger, U
    Kohl, K
    Chen, RT
    Duclos, P
    Heijbel, H
    Jefferson, T
    Loupi, E
    [J]. VACCINE, 2004, 22 (5-6) : 547 - 550
  • [10] Breugelmans, 2011, BMC P, V5, P32